In terms of fibrosis, inhibiting components of hepatic STAT3 activation has shown promise in attenuating hepatic fibrosis, suggesting a complex interplay in liver pathophysiology (Zhao et al., 2021; Lee and Hoe, 2023). The gene discussed is STAT3; the disease is Hepatic fibrosis.